Which type of lymphoma is the most common form of non-Hodgkin lymphoma in adults?

Prepare for the COMLEX Level 2 Exam with an array of challenging multiple-choice questions designed to enhance understanding. Each question includes detailed explanations and hints to facilitate learning. Equip yourself with the knowledge necessary to excel in your osteopathic medical career.

Multiple Choice

Which type of lymphoma is the most common form of non-Hodgkin lymphoma in adults?

Explanation:
Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma in adults, accounting for approximately 30% of all non-Hodgkin lymphoma cases. This subtype is characterized by the rapid growth of large B lymphocytes and can arise in a variety of anatomical locations, including lymph nodes and extranodal sites. DLBCL often presents in a more aggressive manner, leading to significant clinical manifestations such as lymphadenopathy, fevers, night sweats, and weight loss. The management of DLBCL typically involves a combination of chemotherapy and, in some cases, immunotherapy, demonstrating its importance in the landscape of hematologic malignancies. Its prevalence and treatment approach underscore the need for clinicians to be well-acquainted with DLBCL when addressing non-Hodgkin lymphoma in adult patients.

Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma in adults, accounting for approximately 30% of all non-Hodgkin lymphoma cases. This subtype is characterized by the rapid growth of large B lymphocytes and can arise in a variety of anatomical locations, including lymph nodes and extranodal sites. DLBCL often presents in a more aggressive manner, leading to significant clinical manifestations such as lymphadenopathy, fevers, night sweats, and weight loss.

The management of DLBCL typically involves a combination of chemotherapy and, in some cases, immunotherapy, demonstrating its importance in the landscape of hematologic malignancies. Its prevalence and treatment approach underscore the need for clinicians to be well-acquainted with DLBCL when addressing non-Hodgkin lymphoma in adult patients.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy